Antigua and Barbuda vs Libya: Prevalence rate of hypertension in adults aged 30-79
Antigua and Barbuda
42.6
in 2019
Libya
42.7
in 2019
Antigua and Barbuda rank
49th
Libya rank
47th
Prevalence rate of hypertension in adults aged 30-79 over time
- Antigua and Barbuda
- Libya
How they compare
Libya currently reports 42.7 against 42.6 in Antigua and Barbuda, a difference of 0.1.
Across all 30 years both countries report, Libya has been ahead every year.
Antigua and Barbuda ranks 49th and Libya ranks 47th of 194 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Libya | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.67 | 42.84 | 5.17 | Libya |
| 2000s | 40.18 | 44.46 | 4.28 | Libya |
| 2010s | 42.23 | 43.68 | 1.45 | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Antigua and Barbuda or Libya?
- Libya, at 42.7 against 42.6 in Antigua and Barbuda as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Antigua and Barbuda and Libya?
- 0.1, with Libya ahead.
- How many years of comparable data are there for Antigua and Barbuda and Libya?
- 30 years are reported by both, from 1990 to 2019.
- How do Antigua and Barbuda and Libya rank globally for prevalence rate of hypertension in adults aged 30-79?
- Antigua and Barbuda ranks 49th and Libya ranks 47th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.